RNAi-based therapeutics for lung cancer: biomarkers, microRNAs and nanocarriers

Taylor and Francis Group, Expert Opinion on Drug Delivery, 10(15), p. 965-982, 2018

Journal article published in 2018 by Mariana Magalhães

, Ana Figueiras, Ana Cláudia Santos, Francisco Veiga

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by